A Single-arm, Multiple-Dose, Steady-State, Bioavailability Study With Twice Daily Dosing of Lozanoc (65 mg Itraconazole Capsules, Mayne) Taken Regardless of Food

Trial Profile

A Single-arm, Multiple-Dose, Steady-State, Bioavailability Study With Twice Daily Dosing of Lozanoc (65 mg Itraconazole Capsules, Mayne) Taken Regardless of Food

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs Itraconazole (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Sponsors Mayne Pharma
  • Most Recent Events

    • 19 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.
    • 19 Jul 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2016.
    • 19 Jul 2016 Planned initiation date changed from 1 May 2016 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top